Bausch Health Companies | VRX - Current Assets



Bausch Health Companies reported $6.51B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Amgen USD 26.73B 195M Jun/2025
ANI Pharmaceuticals USD 602.63M 66.34M Jun/2025
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
Bausch Health Companies USD 6.51B 782M Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Danaher USD 11B 1.47B Jun/2025
Drreddys Laboratories INR 269.9B 16.88B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
Novo Nordisk 162.71B 11.69B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Prestige Brands USD 480.52M 32.19M Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025
Zoetis USD 5.92B 46M Jun/2025